Evolving Statistical Methods to Facilitate Evaluation of the Causal Association Between Erythropoiesis-Stimulating Agent Dose and Mortality in Nonexperimental Research: Strengths and Limitations-Reference-Cited by-同舟云学术

Evolving Statistical Methods to Facilitate Evaluation of the Causal Association Between Erythropoiesis-Stimulating Agent Dose and Mortality in Nonexperimental Research: Strengths and Limitations

Published:2009-09 Issue:3 Volume:54 Page:554-560
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Bradbury Brian D.,Brookhart M. Alan,Winkelmayer Wolfgang C.,Critchlow Cathy W.,Kilpatrick Ryan D.,Joffe Marshall M.,Feldman Harold I.,Acquavella John F.,Wang Ouhong,Rothman Kenneth J.

Publisher

Elsevier BV

Subject

Nephrology

Reference40 articles.

1. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin;Besarab;N Engl J Med,1998

2. Normalization of hemoglobin level in patients with chronic kidney disease and anemia;Drueke;N Engl J Med,2006

3. Correction of anemia with epoetin alfa in chronic kidney disease;Singh;N Engl J Med,2006

4. USRDS 2004 Annual Data Report,2005

5. Confounding: Essence and detection;Miettinen;Am J Epidemiol,1981

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Handling time‐varying treatments in observational studies: A scoping review and recommendations;Journal of Evidence-Based Medicine;2024-03

2. Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States;Kidney International Reports;2023-12

3. Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study;Clinical and Experimental Nephrology;2020-03-31

4. Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients;American Journal of Nephrology;2017

5. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?;Seminars in Dialysis;2016-10-20